🇸🇬 QSC Peptides Singapore  ·  Order from QSC →

Buy Tirzepatide in Singapore

Asia Warehouse CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  2–5 days  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly — the first of its class to exceed 20% in Phase 3. Ships to Singapore in 2–5 business days from QSC Asia warehouse.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Asia Warehouse to Singapore

From SGD 84 (USD 62) · 2–5 business days. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.

Buy Tirzepatide at QSC →

Singapore Shipping Details

DestinationDelivery Time
Singapore (all districts)2-5 business days
Malaysia (Peninsular)3-6 business days
Malaysia (East: Sabah, Sarawak)5-8 business days
Indonesia (Java, Bali)4-7 business days
Thailand3-6 business days
Philippines5-9 business days
Vietnam4-7 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT

Tirzepatide — Variants and Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
SGD 84
USD 62 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
SGD 135
USD 100 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
SGD 187
USD 138 · Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue, and reduces hepatic gluconeogenesis.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4%. First GLP-1 compound to exceed 20% in a published Phase 3 trial. Singapore ranks among Asia's most active markets for metabolic disease research.

Available Across Singapore

QSC ships Tirzepatide from the Asia regional warehouse to all Singapore districts and planning areas: Central Region (Orchard, Novena, Toa Payoh, Bishan), North Region (Woodlands, Yishun, Sembawang), East Region (Tampines, Pasir Ris, Bedok), West Region (Jurong, Clementi, Buona Vista, one-north), North-East Region (Sengkang, Hougang, Serangoon). Research institutions across the island — A*STAR, NUS, NTU, Duke-NUS, NNI, SGH, TTSH — all within the 2–5 business day delivery window. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016, not a reseller. Purity >=99% HPLC, Janoshik COA verifiable at janoshik.com. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped from QSC Asia regional warehouse.